Somryst® the first and only FDA authorized digital treatment for chronic insomnia using CBT (Cognitive Behavioral Therapy for Insomnia – CBTi) will currently be unavailable. This is due to its parent company Pear Therapeutics, Inc. has filed for a Chapter 11 bancruptcy on April 7, 2023. The debtors voluntarily filed for Chapter 11 bancruptcy protection in the United States Bancruptcy …
